Standout Papers
- Pancreatic Adenocarcinoma (2014)
- Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial (2017)
- Frequent Mutation of Isocitrate Dehydrogenase(IDH)1andIDH2in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping (2011)
- Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma (2018)
Immediate Impact
6 by Nobel laureates 4 from Science/Nature 64 standout
Citing Papers
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
2025 Standout
Pancreatic cancer: Advances and challenges
2023 Standout
Works of David P. Ryan being referenced
Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma
2019
Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| David P. Ryan | 9722 | 3842 | 3543 | 3696 | 417 | 16.7k | |
| Jeffrey W. Clark | 7561 | 4520 | 2378 | 4285 | 344 | 16.5k | |
| David Goldstein | 11518 | 3769 | 2823 | 2677 | 432 | 18.1k | |
| Neal J. Meropol | 12842 | 5102 | 2443 | 3026 | 306 | 19.0k | |
| Donna Niedzwiecki | 11190 | 4631 | 4135 | 3595 | 387 | 18.5k | |
| Julia Brown | 11797 | 3822 | 8304 | 3422 | 345 | 24.3k | |
| Philip S. Rosenberg | 5758 | 2392 | 3168 | 3728 | 245 | 18.1k | |
| Lillian L. Siu | 11372 | 6417 | 3983 | 8050 | 570 | 24.0k | |
| Katherine S. Panageas | 9408 | 4426 | 1921 | 4504 | 312 | 19.0k | |
| Franco M. Muggia | 8258 | 3071 | 3310 | 5025 | 542 | 18.9k | |
| Justin Stebbing | 5945 | 1998 | 1639 | 4230 | 515 | 14.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...